SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950133-04-003421
Filing Date
2004-09-03
Accepted
2004-09-03 14:37:45
Documents
4
Period of Report
2004-09-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K FOR GUILFORD PHARMACEUTICALS, INC. w01646e8vk.htm 8-K 14216
2 EXHIBIT 3.1 w01646exv3w1.htm EX-3.1 53491
3 EXHIBIT 10.1 w01646exv10w1.htm EX-10.1 63704
4 EXHIBIT 99.1 w01646exv99w1.htm EX-99.1 5483
  Complete submission text file 0000950133-04-003421.txt   139003
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23736 | Film No.: 041016523
SIC: 2834 Pharmaceutical Preparations